Company

Karyopharm Therapeutics Inc.

KPTI · CIK 0001503802

SEC FORM 4

$449.82

Sale of 378 shares at $1.19 per share.

Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001193125-26-412209 · filed 2026-10-02 · View filing →

SEC FORM 4

$38.38

Sale of 19 shares at $2.02 per share.

Reporting Person Abate Kristin · Officer Title Chief Accounting Officer · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380404 · filed 2026-09-02 · View filing →